1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > OPKO Health Inc (OPK) - Product Pipeline Analysis, 2016 Update

OPKO Health Inc (OPK) - Product Pipeline Analysis, 2016 Update

  • December 2016
  • -
  • GlobalData
  • -
  • 65 pages

Summary

Table of Contents

Search Inside

Summary
OPKO Health Inc (OPKO), formerly eXegenics Inc, is a biopharmaceutical and diagnostic company. It discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (“LDTs”), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers products and vaccines that are used in the treatment of chronic kidney disease, Parkinson’s disease, asthma, hemophilia, obesity, chronic obstructive pulmonary disease (COPD) and chemotherapy-induced nausea and vomiting, among others. The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada, Brazil and Israel. OPKO is headquartered in Miami, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OPKO Health Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2016 Update

Foundation for Innovative New Diagnostics - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • December 2016
  • by GlobalData

Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that develops and implements new diagnostic technologies for the development of diagnostic tests. The organization’s ...

Population Diagnostics Inc - Product Pipeline Analysis, 2016 Update

Population Diagnostics Inc - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • December 2016
  • by GlobalData

Summary Population Diagnostics Inc (Population Diagnostics) is a biotechnology company that carries out the research, development and discovery of platform technology for validation of causative genetic ...

TheraDiag SA (ALTER) - Product Pipeline Analysis, 2016 Update

TheraDiag SA (ALTER) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • December 2016
  • by GlobalData

Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA is a biotechnology company that develops, manufactures, and markets in-vitro diagnostic products. The company provides product for the ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.